@daviddemesquita's TRT claims need context, we checked
Quick answer
HCG is used as an adjunct to exogenous testosterone therapy to preserve intratesticular testosterone production, testicular volume, and spermatogenesis by mimicking LH at the Leydig cell receptor. Dosing protocols in clinical practice typically range from 250 to 500 IU administered two to three times per week rather than daily, based on evidence that intermittent stimulation reduces LH receptor desensitization and manages estradiol elevation from aromatization. Fertility outcomes following cessation of TRT are variable and depend on duration of suppression, baseline reproductive function, and patient age, not a fixed genetic probability.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @daviddemesquita actually say?
The creator, who identifies as working in "the medical and the functional space" and as an Olympian coach, made several distinct claims about HCG use alongside TRT. He argued that everyone on TRT should use HCG "at least for part of the year," that HCG use gives roughly "a 60% odds of returning with fertility after stopping exogenous hormone use," and that daily HCG dosing is inferior to every-other-day dosing. His reasoning for the dosing preference was physiological: he described the testes as filling, unloading over two days, and reloading in a cyclical pattern, so every-other-day dosing better mimics natural LH pulsatility.
He also mentioned running 200 IU of HCG per day as the practice he was evaluating, and concluded that every-other-day is "the better approach" based on his own experience and conversations with urologists who follow him. Worth noting: the transcript consistently uses "HGG" which appears to be a transcription artifact for HCG (human chorionic gonadotropin).
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 6 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For @daviddemesquita's TRT claims need context, we checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
Understanding weight gain at menopause
Background source for body-composition and weight-change discussions around menopause.
PubMed
Management of obesity in menopause
Current source for menopause-specific obesity management framing.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
@daviddemesquita's TRT claims need context, we checked is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
HCG is used as an adjunct to exogenous testosterone therapy to preserve intratesticular testosterone production, testicular volume, and spermatogenesis by mimicking LH at the Leydig cell receptor.
FormBlends verdict
HCG is used as an adjunct to exogenous testosterone therapy to preserve intratesticular testosterone production, testicular volume, and spermatogenesis by mimicking LH at the Leydig cell receptor. Dosing protocols in clinical practice typically range from 250 to 500 IU administered two to three times per week rather than daily, based on evidence that intermittent stimulation reduces LH receptor desensitization and manages estradiol elevation from aromatization. Fertility outcomes following cessation of TRT are variable and depend on duration of suppression, baseline reproductive function, and patient age, not a fixed genetic probability.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- HCG is used as an adjunct to exogenous testosterone therapy to preserve intratesticular testosterone production, testicular volume, and spermatogenesis by mimicking LH at the Leydig cell receptor. Dosing protocols in clinical practice typically range from 250 to 500 IU administered two to three times per week rather than daily, based on evidence that intermittent stimulation reduces LH receptor desensitization and manages estradiol elevation from aromatization. Fertility outcomes following cessation of TRT are variable and depend on duration of suppression, baseline reproductive function, and patient age, not a fixed genetic probability.
- Coviello et al. (2005, JCEM) showed 250 IU HCG every other day is sufficient to maintain intratesticular testosterone in men on exogenous testosterone, supporting intermittent over daily dosing.
- The '60% fertility recovery' figure cited in the video has no clear source in peer-reviewed literature and should not be taken as a reliable probability.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Coviello et al. (2005, JCEM) showed 250 IU HCG every other day is sufficient to maintain intratesticular testosterone in men on exogenous testosterone, supporting intermittent over daily dosing.
- The '60% fertility recovery' figure cited in the video has no clear source in peer-reviewed literature and should not be taken as a reliable probability.
- HCG aromatizes to estradiol, which the video does not mention. Estrogen management is a real clinical consideration when adding HCG to a TRT protocol.
- Post-TRT spermatogenic recovery can take 12 to 24 months or longer and is influenced by age, duration of suppression, and baseline fertility, not genetics alone.
- Crosnoe et al. (2013, Fertility and Sterility) reviewed post-anabolic androgen recovery and found outcomes are highly variable, with no single recovery rate applicable across patient populations.
- HCG is not approved by the FDA for use in TRT specifically; its application in this context is off-label, and any dosing decision requires a licensed prescriber reviewing individual labs.
- Continuous high-dose HCG can cause LH receptor downregulation, which is the mechanistic basis for preferring lower, intermittent doses, a point the creator got directionally correct.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
David DeMesquita™️ · TikTok creator
17.2K views on this video
Replying to @Mr mayhem #trt #bodybuilding #hrt
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by David DeMesquita™️, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.